paranas
sinus
compris
pair
sinus
maxillari
ethmoid
sphenoid
frontal
roof
ethmoid
sinu
fovea
ethmoidali
form
floor
anterior
cranial
caviti
slope
upward
angl
midlin
extend
mm
cribriform
plate
later
wall
ethmoid
lamina
papyracea
also
medial
wall
orbit
ethmoid
sinus
compris
numer
small
air
cell
develop
evagin
later
nasal
wall
embryo
averag
ethmoid
air
cell
present
although
number
vari
wide
ethmoid
sinu
divid
anterior
posterior
group
air
cell
anterior
group
ethmoid
cell
includ
frontal
recess
bullar
infundibular
cell
infundibulum
site
drainag
frontal
sinu
anterior
ethmoid
cell
locat
later
middl
turbin
anterior
bulla
bullar
cell
drain
middl
meatu
via
hiatu
semilunari
larg
cleft
later
nasal
wall
uncin
process
form
anterior
border
hiatu
semilunari
ridg
bone
extend
ascend
process
maxilla
remain
anterior
ethmoid
cell
drain
middl
meatu
wherea
posterior
cell
drain
sphenoethmoid
recess
vascular
suppli
ethmoid
sinus
anterior
posterior
ethmoid
arteri
innerv
sinus
come
orbit
divis
fifth
cranial
nerv
maxillari
sinus
roughli
triangular
shape
boundari
orbit
floor
superiorli
later
nasal
wall
medial
boni
later
wall
sinu
drain
natur
ostium
superior
medial
wall
flow
hiatu
semilunari
may
also
accessori
maxillari
sinu
ostia
medial
sinu
wall
frontal
sinu
origin
frontal
recess
cell
anterior
ethmoid
birth
often
indistinguish
cell
frontal
sinu
usual
well
form
year
age
reach
adult
size
year
age
anterior
tabl
twice
thick
posterior
tabl
measur
midsagitt
plane
inferiorli
intersinu
septum
separ
two
sinus
sinus
drain
nasofront
recess
hiatu
semilunari
beneath
middl
turbin
adult
recess
mucou
membranelin
boni
canal
measur
mm
greater
ostiomeat
complex
includ
middl
turbin
uncin
process
middl
meatu
hiatu
semilunari
infundibulum
drainag
pathway
frontal
anterior
ethmoid
maxillari
sinus
flow
ostiomeat
complex
obstruct
rel
narrow
path
polyp
mass
lesion
inflammatori
edema
purul
result
postobstruct
sinus
involv
one
aforement
sinus
sphenoid
sinus
origin
evagin
sphenoethmoid
recess
present
birth
begin
pneumat
year
age
develop
sinus
may
continu
adulthood
size
may
vari
greatli
differ
degre
develop
midlin
often
irregularli
shape
intersinu
septum
drainag
sphenoethmoid
recess
medial
superior
turbin
superior
boundari
sella
pituitari
fossa
wherea
later
wall
contain
optic
nerv
carotid
arteri
cavern
sinu
may
boni
dehisc
later
wall
structur
paranas
sinus
line
respiratori
epithelium
consist
pseudostratifi
ciliat
columnar
epithelium
goblet
cell
numer
mucou
serosanguin
gland
present
addit
mucu
sinu
gland
also
secret
complementari
integr
treatment
rhinosinus
immunoglobulin
interferon
lysozym
anterior
portion
nare
nasal
septum
cover
skin
adnexa
roof
nasal
caviti
contain
special
olfactori
epithelium
bipolar
olfactori
neuron
sinu
epithelium
form
mucociliari
system
suppli
nose
mucou
cover
warm
humidifi
inspir
air
parasympathet
sympathet
nerv
suppli
mucou
blanket
renew
everi
minut
cilia
beat
time
per
second
move
mucou
blanket
toward
natur
ostia
sinus
environment
factor
influenc
ciliari
function
humid
increas
activ
wherea
dehydr
cold
temperatur
decreas
flow
bacteri
viral
prolifer
may
increas
dysfunct
cilia
rel
stasi
mucou
blanket
addit
mucociliari
dysfunct
condit
obstruct
drainag
sinus
eg
polyp
inflamm
edema
nasal
mucosa
lead
sinus
benign
malign
tumor
nasal
caviti
paranas
sinus
skull
base
also
lead
postobstruct
sinus
one
paranas
sinus
varieti
host
environment
factor
play
role
develop
rs
host
factor
divid
gener
genet
factor
immun
defici
local
anatom
abnorm
mucos
bone
inflamm
environment
factor
air
pollut
smoke
allergen
virus
bacteria
fungi
pathophysiolog
lead
rs
maxillari
frontal
sinus
usual
involv
constel
chang
lead
obstruct
ostiomeat
complex
includ
mucos
swell
inflamm
mucou
stasi
impair
mucociliari
function
microbi
infect
late
sever
differ
theori
emerg
describ
pathophysiolog
involv
chronic
rs
especi
recalcitr
natur
includ
inflamm
fungalmedi
hypersensit
bacteri
biofilm
osteiti
superantigen
novel
therapi
target
toward
specif
area
condit
consid
mimic
chronic
rs
includ
gastroesophag
reflux
diseas
adenoid
thornwaldt
cyst
dental
infect
granulomat
disord
neoplasia
sign
symptom
rs
differ
depend
upon
contribut
factor
overal
durat
acut
rs
often
present
purul
nasal
discharg
nasal
obstruct
facial
pain
pressur
addit
symptom
includ
hyposmia
anosmia
headach
fever
cough
aural
full
halitosi
fatigu
dental
pain
purul
nasal
discharg
use
sole
factor
distinguish
viral
bacteri
infect
ill
pattern
durat
use
instead
viral
rs
usual
last
less
day
acut
bacteri
rs
persist
chronic
rs
exist
symptom
continu
greater
week
goal
treatment
improv
drainag
remov
obstruct
promot
mucociliari
function
erad
infect
reduc
inflamm
prevent
complic
medic
therapi
rs
includ
follow
intranas
system
steroid
topic
oral
antibiot
nasal
salin
irrig
topic
system
decongest
antihistamin
leukotrien
antagonist
mucolyt
expector
immunotherapi
analges
convent
therapi
effect
symptom
becom
refractori
medic
option
use
includ
antifung
protonpump
inhibitor
bacteri
lysat
immunomodul
immunostimul
longterm
lowdos
macrolid
therapi
may
also
role
treatment
chronic
rs
given
demonstr
antiinflammatori
effect
endoscop
sinu
surgeri
indic
reason
fail
medic
treatment
potenti
actual
complic
develop
mucocel
mucopyocel
orbit
abscess
invas
fungal
sinus
anatom
obstruct
caus
polyp
mass
lesion
suspicion
malign
substanti
evid
exist
support
surgic
intervent
reduc
symptom
improv
qualiti
life
patient
rs
south
africa
pelargonium
sidoid
p
sidoid
histor
use
treat
varieti
ailment
includ
upper
respiratori
tract
infect
like
bronchiti
tuberculosi
p
sidoid
tradit
known
umckaloabo
rich
phenol
flavonoid
consist
coumarin
tannin
diterpen
proanthocyanidin
standard
germani
aqueou
ethanol
extract
root
known
ep
ep
shown
signific
antibacteri
activ
multiresist
staphylococcu
aureu
antivir
effect
season
influenza
viru
strain
respiratori
syncyti
viru
human
coronaviru
parainfluenza
viru
coxsacki
viru
immunomodulatori
effect
ep
demonstr
specif
enhanc
human
peripher
blood
phagocyt
activ
well
antiadhes
effect
interact
bacteri
surfac
bind
factor
doubleblind
random
multicent
trial
conduct
bachert
colleagu
enrol
patient
radiograph
clinic
confirm
acut
rs
compar
ep
extract
solvent
ethanol
dosag
drop
time
daili
day
placebo
ep
found
superior
efficaci
toler
base
chang
sinus
sever
score
cochran
review
conclud
p
sidoid
may
effect
allevi
symptom
includ
headach
nasal
discharg
acut
rs
common
cold
adult
bromelain
bromelain
mixtur
proteolyt
enzym
extract
pineappl
anana
comosu
demonstr
antiinflammatori
antiedemat
antithrombot
fibrinolyt
effect
three
doubleblind
random
control
trial
conduct
patient
acut
chronic
rs
use
similar
protocol
parallel
treatment
arm
compar
bromelain
placebo
group
also
receiv
convent
manag
consist
antibiot
decongest
antihistamin
analges
metaanalysi
perform
guo
colleagu
show
complementari
integr
treatment
rhinosinus
small
statist
signific
differ
favor
adjunct
treatment
bromelain
nasal
mucos
inflamm
nasal
discomfort
breath
difficulti
overal
rate
nasal
discharg
recent
multicent
trial
enrol
children
less
year
age
acut
sinus
treatment
group
bromelain
vs
bromelain
standard
therapi
vs
standard
therapi
show
statist
signific
recoveri
time
bromelain
monotherapi
compar
treatment
group
one
mild
selflimit
allerg
reaction
note
german
commiss
e
monograph
conclud
bromelain
may
effect
acut
postop
posttraumat
swell
especi
nose
paranas
sinus
caution
must
use
prescrib
bromelain
patient
alreadi
anticoagul
increas
risk
bleed
well
prescrib
variou
antibiot
penicillin
tetracyclin
bromelain
also
known
promot
absorpt
moreov
bromelain
strongli
inhibit
human
cytochrom
activ
therebi
affect
metabol
substrat
recommend
dosag
rang
mgd
cineol
cineol
specif
monoterpen
present
mani
plantbas
essenti
oil
commonli
deriv
eucalyptu
globulu
also
one
main
chemic
ingredi
identifi
chines
herb
flo
magnolia
shown
enhanc
mucociliari
clearanc
block
inflamm
inhibit
format
cytokin
tumor
necrosi
factor
tnf
alpha
activ
antinocicept
properti
perhap
mechan
involv
nonopioid
receptor
prospect
random
doubleblind
studi
compar
cineol
mg
time
per
day
placebo
patient
acut
nonpurul
rs
show
statist
signific
differ
symptom
sum
score
cineol
group
addit
reduct
secondari
symptom
headach
bend
frontal
headach
nasal
obstruct
nasal
secret
mild
side
effect
includ
heartburn
exanthema
note
cineol
investig
conclud
cineol
may
serv
integr
therapi
first
day
acut
rs
antibiot
initi
symptom
persist
addit
anoth
prospect
random
doubleblind
studi
demonstr
cineol
effect
herbal
prepar
differ
compon
treatment
acut
viral
rs
cod
liver
oil
cod
liver
oil
rich
fatti
acid
vitamin
histor
use
remedi
ricket
limit
evid
use
cod
liver
oil
rs
includ
openlabel
studi
enrol
children
recurr
chronic
rs
given
escal
dose
cod
liver
oil
multivitamin
selenium
three
patient
demonstr
posit
respons
decreas
sinu
symptom
fewer
episod
acut
sinus
fewer
physician
visit
investig
conclud
cod
liver
oil
combin
multivitamin
contain
selenium
inexpens
noninvas
adjunct
intervent
use
select
patient
manuka
honey
produc
nectar
flower
nativ
australia
new
zealand
particularli
speci
leptospermum
potent
antibacteri
activ
attribut
high
concentr
methylglyox
hyperosmolar
hydrogen
peroxid
low
ph
found
bactericid
activ
biofilm
form
pseudomona
aeruginosa
staphylococcu
aureu
significantli
higher
effect
commonli
use
antibiot
may
implic
treat
chronic
rs
thamboo
colleagu
studi
use
manuka
honey
patient
allerg
fungal
rs
thirtyfour
patient
treat
topic
combin
manuka
honey
salin
one
nostril
daili
day
cultur
result
ethmoid
caviti
unchang
endoscop
stage
howev
report
symptomat
improv
use
sinonas
outcom
test
snot
outcom
measur
sinupret
sinupret
compris
gentiana
radix
primula
flo
rumex
herba
sambucu
flo
verbena
herba
herbal
formula
use
wide
germani
treatment
respiratori
infect
approv
german
commiss
e
treatment
acut
chronic
inflamm
paranas
sinus
sinupret
avail
coat
tablet
mg
gentiana
radix
mg
primula
flo
rumex
herba
sambucu
flo
verbena
herba
water
alcohol
extract
proport
sinupret
shown
antivir
activ
vitro
certain
subtyp
virus
known
caus
respiratori
infect
includ
adenoviru
human
rhinoviru
respiratori
syncyti
viru
strongli
stimul
transepitheli
cl
secret
maintain
normal
mucociliari
clearanc
sinonas
epithelium
hydrat
airway
surfac
liquid
four
random
control
trial
rct
evalu
sinupret
either
tablet
drop
liquid
formula
time
per
day
adjunct
therapi
acut
rs
rct
chronic
rs
rct
berghorn
langer
w
rz
rw
bionorica
gmbh
unpublish
data
systemat
review
demonstr
sinupret
may
effect
adjunct
therapi
acut
rs
howev
one
studi
found
signific
differ
olfactori
function
patient
treat
sinupret
versu
placebo
although
initi
therapi
oral
prednisolon
day
preced
treatment
intervent
esberitox
esberitox
herbal
extract
contain
thuja
occidentali
white
cedar
echinacea
purpurea
pallida
purpl
coneflow
baptisia
tinctoria
wild
indigo
demonstr
immunomodulatori
properti
random
doubleblind
placebocontrol
studi
show
dosedepend
efficaci
treatment
upper
respiratori
infect
particular
certain
symptom
like
rhinorrhea
anoth
studi
enrol
patient
acut
rs
compar
esberitox
tablet
time
per
day
doxycyclin
sinupret
tablet
twice
per
day
doxycyclin
doxycyclin
alon
found
group
combin
therapi
significantli
higher
rate
respons
report
advers
event
includ
photosensit
gastrointestin
symptom
nausea
myrtol
standard
phytotherapeut
extract
gelomyrtolgelomyrtol
fort
taken
pinu
spp
citru
aurantifolia
eucalyptu
globulu
mainli
compris
random
doubleblind
multicent
trial
patient
acut
sinus
enrol
one
arm
myrtol
extract
mgd
unidentifi
essenti
oil
placebo
myrtol
essenti
oil
group
demonstr
superior
efficaci
placebo
base
total
symptom
score
item
headach
nasal
secret
nasal
obstruct
pain
pressur
pain
bend
gener
wellb
fever
although
insuffici
statist
data
support
conclus
mild
moder
advers
event
mostli
gastrointestin
natur
report
nasturtium
tropaeoli
majori
herba
horseradish
root
armoracia
rusticana
radix
broad
antibacteri
activ
sever
gramposit
gramneg
organ
includ
haemophilu
influenza
moraxella
catarrhali
pseudomona
aeruginosa
staphylococcu
aureu
streptococcu
pyogen
prospect
multicent
cohort
studi
perform
children
year
age
acut
rs
found
herbal
drug
prepar
contain
nasturtium
horseradish
root
similar
efficaci
fewer
advers
event
compar
standard
antibiot
dietari
polyphenol
wide
avail
food
wellknown
antiinflammatori
effect
ginger
quercetin
polyphenol
bioflavonoid
commonli
found
appl
onion
potent
antioxid
antiinflammatori
properti
mechan
action
elucid
quercetin
includ
suppress
inflammatori
mediat
inhibit
histamin
releas
downregul
mast
cell
activ
enhanc
mucociliari
clearanc
augment
transepitheli
chlorid
secret
via
cystic
fibrosi
transmembran
conduct
regul
anion
channel
combin
ginger
extract
green
tea
camellia
sinensi
rich
epigallocatechin
gallat
egcg
show
signific
antiallergi
effect
suppress
certain
cytokin
tnfalpha
macrophag
inflammatori
protein
dietari
polyphenol
gingerol
quercetin
egcg
found
effect
inhibit
excess
mucu
secret
respiratori
epitheli
cell
maintain
normal
nasal
ciliari
movement
homeopathi
homeopathi
initi
develop
german
physician
samuel
christian
hahnemann
end
eighteenth
centuri
base
principl
similar
like
cure
like
wherebi
therapeut
effect
achiev
stimul
bodi
homeostat
heal
respons
via
substanc
serial
dilut
shaken
evid
rct
homeopathi
may
effect
treatment
influenza
allergi
recent
prospect
observ
trial
germani
adult
patient
treatment
refractori
chronic
sinus
tri
differ
homeopath
remedi
cours
year
investig
found
sustain
improv
qualityoflif
outcom
short
form
health
survey
decreas
use
convent
medic
greatest
chang
note
first
month
followup
sinfront
sinfront
homeopath
remedi
contain
cinnabari
ferrum
phosphoricum
mercuriu
solubili
commonli
use
germani
varieti
upper
respiratori
tract
infect
shown
promis
treatment
rs
without
taw
et
al
need
antibiot
prospect
random
doubleblind
placebocontrol
multicent
clinic
trial
compar
sinfront
placebo
patient
radiographyconfirm
acut
maxillari
sinus
found
signific
differ
patient
treat
sinfront
recurr
symptom
week
treatment
patient
receiv
sinfront
instruct
take
tablet
everi
hour
improv
note
maximum
tablet
per
day
dose
would
chang
tablet
time
per
day
econom
analysi
demonstr
sinfront
lead
substanti
cost
save
markedli
reduc
absente
work
tradit
chines
medicin
tcm
whole
medic
system
use
sever
millennia
therapeut
use
tcm
chines
herbal
medicin
acupunctur
grown
popular
parallel
increas
scientif
understand
elucid
mechan
specif
use
tcm
treatment
disord
involv
ear
nose
throat
trace
back
earli
fifth
centuri
bc
sever
therapi
may
benefici
rs
therapeut
effect
acupunctur
primarili
stem
reestablish
homeostasi
multipl
physiolog
cascad
whether
modul
immun
system
inflammatori
respons
autonom
nervou
system
neuroendocrin
axi
limbic
system
pain
pathway
although
acupunctur
may
modul
mani
cascad
treatment
patient
rs
specif
effect
improv
mucociliari
clearanc
airway
surfac
liquid
also
demonstr
prospect
random
studi
patient
nasal
congest
hypertroph
inferior
turbin
treat
acupunctur
found
signific
improv
visual
analog
scale
nasal
airflow
measur
activ
anterior
rhinomanometri
anoth
studi
demonstr
reduct
sinusrel
pain
compar
placebo
group
acupunctur
also
demonstr
benefici
result
treatment
children
chronic
maxillari
sinus
research
team
norway
conduct
differ
studi
use
similar
protocol
wherebi
patient
chronic
rs
random
arm
tradit
chines
acupunctur
sham
acupunctur
convent
medic
manag
antibiot
oral
steroid
nasal
salin
irrig
local
decongest
studi
improv
healthrel
qualityoflif
symptom
score
group
although
overal
statist
signific
differ
among
xanthii
fructu
chines
herbal
name
cang
er
zi
flo
magnolia
chines
herbal
name
xin
yi
hua
commonli
use
herb
tradit
chines
medicin
treat
rs
xanthii
fructu
also
known
xanthium
sibiricum
former
simpli
fruit
latter
tcm
perspect
xanthii
fructu
dispers
wind
damp
treat
thick
viscou
nasal
discharg
sinusrel
headach
wherea
flo
magnolia
use
expel
windcold
treat
nasal
discharg
hyposmia
sinu
congest
headach
fact
two
herb
often
combin
key
compon
chines
herbal
formula
cang
er
zi
wan
cang
er
zi
san
pill
powder
prepar
respect
import
note
chines
herb
use
guidanc
tcm
theori
chines
herb
use
accord
tcm
principl
sever
complementari
integr
treatment
rhinosinus
advers
event
occur
one
exampl
inappropri
use
ephedra
chines
name
huang
weight
loss
increas
energi
perform
enhanc
tradit
use
upper
respiratori
infect
short
period
time
much
like
pseudoephedrin
use
briefli
symptom
relat
upper
respiratori
infect
xanthii
fructu
chines
name
cang
er
zi
murin
model
xanthii
fructu
found
exhibit
antiinflammatori
effect
inhibit
interferongamma
tnfalpha
lipopolysaccharideinduc
nitric
oxid
synthesi
antiallerg
effect
block
mast
cellmedi
histamin
releas
antioxid
effect
increas
activ
catalas
superoxid
dismutas
glutathion
peroxidas
liver
enhanc
radic
scaveng
reduc
activ
sesquiterpen
lacton
xanthatin
specif
compon
xanthium
sibiricum
display
signific
antibacteri
activ
methicillinresist
staphylococcu
aureu
also
inhibit
bacteria
like
staphylococcu
epidermidi
klebsiella
pneumonia
bacillu
cereu
pseudomona
aeruginosa
salmonella
typhi
zhao
colleagu
found
xanthii
fructu
abl
modul
proinflammatori
cytokin
inhibit
human
mast
cell
peripher
blood
mononuclear
cell
demonstr
shibilin
modifi
version
chines
herbal
formula
cang
er
zi
san
amelior
nasal
symptom
sneez
nasal
scratch
guinea
pig
model
reduc
nasal
thromboxan
eosinophil
infiltr
endotheli
nitric
oxid
synthas
activ
doubleblind
rct
enrol
patient
allerg
rhiniti
equal
cohort
receiv
shibilin
placebo
found
shibilin
significantli
improv
symptom
sustain
respons
least
week
treatment
howev
caution
must
exercis
use
either
xanthii
fructu
cang
er
zi
wan
shown
lead
certain
side
effect
like
muscl
spasm
hepatotox
nephrotox
flo
magnolia
chines
herbal
name
xin
yi
hua
primari
bioactiv
compon
flo
magnolia
includ
terpenoid
lignan
neolignan
epimagnolin
fargesin
neolignan
found
antiinflammatori
effect
mechan
action
differ
steroid
epimagnolin
fargesin
decreas
product
nitric
oxid
potent
mediat
inflamm
inhibit
induc
nitric
oxid
synthas
express
flo
magnolia
also
demonstr
antiallergi
activ
via
inhibit
immediatetyp
hypersensit
reaction
block
mast
cell
degranul
essenti
oil
main
chemic
ingredi
identifi
sabinen
betapinen
alphapinen
transcaryophyllen
bi
yuan
shu
chines
herbal
liquid
mixtur
compris
unknown
number
herb
report
includ
least
magnolia
liliflora
xanthium
strumarium
astragalu
membranaceu
angelica
dahurica
scutellaria
baicalensi
multicent
rct
divid
postop
patient
chronic
rs
nasal
polyp
undergon
endoscop
sinu
surgeri
group
group
receiv
antibiot
topic
steroid
test
group
also
treat
bi
yuan
shu
ml
time
per
day
adjunct
treatment
bi
yuan
shu
found
significantli
higher
respons
rate
day
purul
nasal
discharg
breath
difficulti
pain
hyposmia
halitosi
posit
trend
note
fever
cough
anoth
studi
assess
efficaci
chines
herbal
medicin
care
patient
undergo
endoscop
sinu
surgeri
enrol
patient
one
treatment
arm
tsangerhsan
extract
granul
houttuynia
extract
powder
oral
amoxicillin
placebo
studi
found
benefit
either
treatment
group
placebo
multicent
nonrandom
studi
patient
acut
rs
compar
multipl
convent
antibiot
secretolyt
sympathomimet
combin
complementari
sinupret
homeopath
remedi
cinnabari
therapi
demonstr
similar
effect
base
patient
selfassess
score
physician
score
questionnair
howev
valid
outcom
paramet
qualityoflif
instrument
limit
studi
includ
small
sampl
size
lack
random
blind
recent
pilot
studi
univers
california
lo
angel
conduct
use
integr
eastwest
medicin
treat
patient
recalcitr
chronic
rs
eleven
patient
underw
weekli
session
sequenti
acupunctur
tabl
therapeut
acupressur
style
massag
receiv
educ
consist
dietari
modif
lifestyl
chang
selfacupressur
four
item
need
blow
nose
runni
nose
reduc
concentr
frustratedrestlessirrit
domain
role
physic
vital
social
function
show
statist
signific
differ
wherea
trend
improv
note
element
qualityoflif
instrument
although
data
look
promis
studi
also
limit
small
size
lack
random
control
group
lifestyl
modif
also
conduc
toward
achiev
optim
sinu
health
function
modif
includ
regular
aerob
exercis
adequ
hydrat
steam
inhal
stress
manag
goodqual
sleep
minim
exposur
pollut
smoke
environment
toxin
well
incorpor
nutrit
chang
consum
antiinflammatori
diet
avoid
dairi
product
refin
sugar
process
food
import
regular
spiritu
practic
prayer
also
benefici
along
anger
manag
attitud
forgiv
gratitud
optim
selfacupressur
certain
acupoint
also
help
reduc
sinusrel
symptom
see
tabl
gain
greater
understand
complex
pathogenesi
rs
becom
appar
shift
philosoph
paradigm
previou
reductionist
model
diseas
health
replac
holism
system
biolog
complex
nonlinear
dynam
holism
central
philosoph
underpin
integr
medicin
mani
cim
modal
tcm
see
paradigm
shift
approach
rs
longer
medic
commun
look
diagnosi
rs
sole
infecti
process
rather
complex
multifactori
exampl
palmer
elegantli
describ
transit
wherebi
gener
doctor
scientist
taught
envis
bacteria
singl
cell
float
swim
fluid
fact
rhinologist
continu
foster
view
howev
biofilm
singl
cell
structur
metabol
heterogen
multicellular
commun
biofilm
demonstr
celltocel
signal
phenomenon
known
quorum
sens
exampl
complex
scienc
holism
therapeut
repertoir
likewis
broaden
significantli
antibiot
alon
mainstay
treatment
use
multipl
therapi
act
differ
pathophysiolog
facet
rs
integr
medicin
provid
expand
approach
armamentarium
help
patient
rs
whether
acut
chronic
recalcitr
